loadpatents
Patent applications and USPTO patent grants for Beals; John Michael.The latest application filed is for "fusion proteins".
Patent | Date |
---|---|
Fusion Proteins App 20220211818 - Baldwin; David Bruce ;   et al. | 2022-07-07 |
Pharmaceutical Combinations Comprising Insulin And At Least An Agent Selected From Meloxicam, Bromfenac Sodium, Acetylsalicylic Acid, Salicyclic Acid And Paracetamol App 20220175891 - BEALS; John Michael ;   et al. | 2022-06-09 |
Fusion proteins and methods of use Grant 11,253,574 - Baldwin , et al. February 22, 2 | 2022-02-22 |
Fusion Proteins App 20200390865 - Baldwin; David Bruce ;   et al. | 2020-12-17 |
Pharmaceutical Combinations Comprising Insulin And At Least An Agent Selected From Meloxicam, Bromfenac Sodium, Acetylsalicylic App 20200261545 - BEALS; John Michael ;   et al. | 2020-08-20 |
Fusion proteins Grant 10,709,766 - Baldwin , et al. | 2020-07-14 |
Blood glucose lowering compound Grant 10,035,839 - Baldwin , et al. July 31, 2 | 2018-07-31 |
Fusion Proteins App 20180177851 - Baldwin; David Bruce ;   et al. | 2018-06-28 |
Fusion proteins Grant 9,855,318 - Baldwin , et al. January 2, 2 | 2018-01-02 |
Blood Glucose Lowering Compound App 20170240614 - BALDWIN; David Bruce ;   et al. | 2017-08-24 |
Fusion Proteins App 20160324932 - Baldwin; David Bruce ;   et al. | 2016-11-10 |
Treatment for comorbid diabetes with chronic kidney disease Grant 9,259,479 - Sinha , et al. February 16, 2 | 2016-02-16 |
Pegylated Insulin Lispro Compounds App 20150297681 - Beals; John Michael ;   et al. | 2015-10-22 |
PEGylated insulin lispro compounds Grant 9,050,371 - Beals , et al. June 9, 2 | 2015-06-09 |
Treatment For Comorbid Diabetes With Chronic Kidney Disease App 20150111819 - Sinha; Vikram Paritosh ;   et al. | 2015-04-23 |
Pegylated Insulin Lispro Compounds App 20110105392 - Beals; John Michael ;   et al. | 2011-05-05 |
Pegylated Insulin Lispro Compounds App 20090312236 - Beals; John Michael ;   et al. | 2009-12-17 |
Muteins Of Fibroblast Growth Factor 21 App 20090118190 - Beals; John Michael ;   et al. | 2009-05-07 |
Muteins of fibroblast growth factor 21 Grant 7,491,697 - Beals , et al. February 17, 2 | 2009-02-17 |
Heterologous G-Csf Fusion Proteins App 20080108560 - Beals; John Michael ;   et al. | 2008-05-08 |
Muteins of fibroblast growth factor 21 App 20070142278 - Beals; John Michael ;   et al. | 2007-06-21 |
Erythropoietic compounds App 20070100133 - Beals; John Michael ;   et al. | 2007-05-03 |
Anti-interleukin-1 beta analogs App 20050070692 - Beals, John Michael ;   et al. | 2005-03-31 |
Insulin molecule having protracted time action App 20050014679 - Beals, John Michael ;   et al. | 2005-01-20 |
Hyperglycosylated polypeptides App 20040254351 - Beals, John Michael ;   et al. | 2004-12-16 |
Treating musculoskeletal disorders using lp85 and analogs thereof App 20030100502 - Beals, John Michael ;   et al. | 2003-05-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.